Variant report
Variant | esv1848150 |
---|---|
Chromosome Location | chr12:62393257-62394361 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:62392186..62394939-chr12:62398107..62400504,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7316605 | chr12:62393257-62393258 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs186891831 | chr12:62393261-62393262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs192094307 | chr12:62393287-62393288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs534600376 | chr12:62393334-62393335 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs184030708 | chr12:62393386-62393387 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs540073022 | chr12:62393399-62393400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs559910696 | chr12:62393420-62393421 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs77269478 | chr12:62393424-62393425 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs529004689 | chr12:62393426-62393427 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs554472316 | chr12:62393435-62393436 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs377042688 | chr12:62393447-62393448 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs187547298 | chr12:62393460-62393461 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs551067264 | chr12:62393462-62393463 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs574090262 | chr12:62393478-62393479 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs75483527 | chr12:62393525-62393526 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs527371409 | chr12:62393557-62393558 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs137960500 | chr12:62393558-62393559 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs149494461 | chr12:62393576-62393577 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs564452886 | chr12:62393602-62393603 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs536803000 | chr12:62393679-62393680 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs556597645 | chr12:62393758-62393759 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs7306011 | chr12:62393793-62393794 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs74096157 | chr12:62393825-62393826 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs189748106 | chr12:62393862-62393863 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs572249606 | chr12:62393912-62393913 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs375325531 | chr12:62393956-62393957 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs371737099 | chr12:62393990-62393991 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs377360675 | chr12:62394009-62394010 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs541128273 | chr12:62394127-62394128 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs367870350 | chr12:62394128-62394129 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs559709546 | chr12:62394144-62394145 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs77568499 | chr12:62394184-62394185 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs573514990 | chr12:62394201-62394202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs182095696 | chr12:62394220-62394221 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs144036018 | chr12:62394244-62394245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs7956690 | chr12:62394258-62394259 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs545028124 | chr12:62394260-62394261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs56221149 | chr12:62394266-62394267 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lissencephaly | 21572526 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 19602461 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
liposarcomas | 17372913 | CNVD |
Non-small cell lung cancer | 24170126 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21785460 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Leukemia | 18628472 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Glaucoma | 21310917 | CNVD |
Breast cancer | 16272173 | CNVD |
Mental retardation | 19951919 | CNVD |
Glaucoma | 21447600 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Developmental delay | 21267005 | CNVD |
12q14 microdeletion syndrome | 21267005 | CNVD |
Developmental delay | 19277063 | CNVD |
Dwarfism | 19277063 | CNVD |
Fibroblasts | 20926602 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 20080666 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 17133270 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Glioblastoma | 17090523 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Lung cancer | 16773561 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Breast cancer | 21364760 | CNVD |
Man infertility | 21397064 | CNVD |
Mental retardation | 17220210 | CNVD |
Osteopoikilosis | 17220210 | CNVD |
short stature | 17220210 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Schizophrenia | 21346763 | CNVD |
Breast cancer | 20369283 | CNVD |
Schizophrenia | 20967226 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:62391200-62393600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
2 | chr12:62392600-62393400 | Enhancers | Adipose Nuclei | Adipose |
3 | chr12:62392600-62393600 | Enhancers | Primary monocytes fromperipheralblood | blood |
4 | chr12:62392600-62394200 | Enhancers | Primary neutrophils fromperipheralblood | blood |
5 | chr12:62393000-62393400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
6 | chr12:62393200-62393600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
7 | chr12:62393400-62396600 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
8 | chr12:62393600-62396600 | Weak transcription | Primary monocytes fromperipheralblood | blood |